{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:07:18Z","timestamp":1791986838266,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.eururo.2025.12.028","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:04:47Z","timestamp":1768424687000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Hype and the Hope: Where Do We Stand with Prostate-specific Membrane Antigen\u2013targeted Fluorescence-guided Surgery?"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1791-201X","authenticated-orcid":false,"given":"Vera A.","family":"Ottens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Contieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fijs W.B.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk G.","family":"van der Poel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2025.12.028_b0005","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.euo.2023.11.021","article-title":"Assessing the impact of positive surgical margins on mortality in patients who underwent robotic radical prostatectomy: 20 years\u2019 report from the EAU Robotic Urology Section Scientific Working Group","volume":"7","author":"Pellegrino","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.12.028_b0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prnil.2022.12.005","article-title":"Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates","volume":"11","author":"Nagaya","year":"2023","journal-title":"Prostate Int"},{"key":"10.1016\/j.eururo.2025.12.028_b0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(23)00102-X","article-title":"First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial","volume":"24","author":"Stibbe","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2025.12.028_b0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.euo.2023.07.004","volume":"7","author":"Nguyen","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.12.028_b0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.clgc.2021.03.011","article-title":"Small molecule, multimodal, [18F]-PET and fluorescence imaging agent targeting prostate-specific membrane antigen: first-in-human study","volume":"19","author":"Aras","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2025.12.028_b0030","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00259-024-06713-x","article-title":"First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy","volume":"51","author":"Hamdy","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eururo.2025.12.028_b0035","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1021\/acs.jmedchem.4c02989","article-title":"Synthesis, preclinical evaluation, and first-in-human assessment of ICG-PSMA-D5: a PSMA-targeted probe for fluorescence-guided surgery of prostate cancer","volume":"68","author":"Chen","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.eururo.2025.12.028_b0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.eururo.2025.03.010","article-title":"First-in-human study of a dual-modality prostate-specific membrane antigen-targeted probe for preoperative positron emission tomography\/computed tomography imaging and intraoperative fluorescence imaging in prostate cancer","volume":"87","author":"Chen","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.12.028_b0045","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00259-020-05184-0","article-title":"The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET\/CT and intraoperative fluorescence imaging","volume":"48","author":"Eder","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eururo.2025.12.028_b0050","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.eururo.2022.06.002","volume":"82","author":"Gandaglia","year":"2022","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826000096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826000096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:04:49Z","timestamp":1768424689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283826000096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":10,"alternative-id":["S0302283826000096"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2025.12.028","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Hype and the Hope: Where Do We Stand with Prostate-specific Membrane Antigen\u2013targeted Fluorescence-guided Surgery?","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2025.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}